Search Page

1

Cite

Share

Surgeon specialty is associated with outcome in rectal cancer treatment.

Read TE, Myerson RJ, Fleshman JW, Fry RD, Birnbaum EH, Walz BJ, Kodner IJ. Read TE, et al. Among authors: myerson rj. Dis Colon Rectum. 2002 Jul;45(7):904-14. doi: 10.1007/s10350-004-6327-5. Dis Colon Rectum. 2002. PMID: 12130879

Cite

Share

2

Cite

Share

Simultaneous radiotherapy and superficial hyperthermia for high-risk breast carcinoma: a randomised comparison of treatment sequelae in heated versus non-heated sectors of the chest wall hyperthermia.

Varma S, Myerson R, Moros E, Taylor M, Straube W, Zoberi I. Varma S, et al. Int J Hyperthermia. 2012;28(7):583-90. doi: 10.3109/02656736.2012.705216. Epub 2012 Sep 4. Int J Hyperthermia. 2012. PMID: 22946861 Free PMC article. Clinical Trial.

Cite

Share

3

Cite

Share

A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma.

Cho M, Wang-Gillam A, Myerson R, Gao F, Strasberg S, Picus J, Sorscher S, Fournier C, Nagaraj G, Parikh P, Suresh R, Linehan D, Tan BR. Cho M, et al. HPB (Oxford). 2015 Jul;17(7):587-93. doi: 10.1111/hpb.12413. Epub 2015 Mar 20. HPB (Oxford). 2015. PMID: 25800066 Free PMC article. Clinical Trial.

Cite

Share

4

Cite

Share

Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.

Martenson JA Jr, Willett CG, Sargent DJ, Mailliard JA, Donohue JH, Gunderson LL, Thomas CR Jr, Fisher B, Benson AB 3rd, Myerson R, Goldberg RM. Martenson JA Jr, et al. J Clin Oncol. 2004 Aug 15;22(16):3277-83. doi: 10.1200/JCO.2004.01.029. Epub 2004 Jul 12. J Clin Oncol. 2004. PMID: 15249584 Clinical Trial.

Cite

Share

5

Cite

Share

A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma.

Lin LL, Picus J, Drebin JA, Linehan DC, Solis J, Strasberg SM, Tan B, Thorstad WL, Myerson R. Lin LL, et al. Am J Clin Oncol. 2005 Jun;28(3):234-41. doi: 10.1097/01.coc.0000156920.11091.12. Am J Clin Oncol. 2005. PMID: 15923794 Clinical Trial.

Cite

Share

6

Cite

Share

Effect of high-dose stereotactic body radiation therapy on liver function in the treatment of primary and metastatic liver malignancies using the Child-Pugh score classification system.

Dyk P, Weiner A, Badiyan S, Myerson R, Parikh P, Olsen J. Dyk P, et al. Pract Radiat Oncol. 2015 May-Jun;5(3):176-182. doi: 10.1016/j.prro.2014.09.007. Epub 2014 Nov 6. Pract Radiat Oncol. 2015. PMID: 25423889 Clinical Trial.

Cite

Share

7

Cite

Share

Salvage surgery after failed chemoradiation for anal canal cancer: should the paradigm be changed for high-risk tumors?

Stewart D, Yan Y, Kodner IJ, Birnbaum E, Fleshman J, Myerson R, Dietz D. Stewart D, et al. J Gastrointest Surg. 2007 Dec;11(12):1744-51. doi: 10.1007/s11605-007-0232-x. Epub 2007 Sep 6. J Gastrointest Surg. 2007. PMID: 17846856

Cite

Share

8

Cite

Share

Technical aspects of image-based treatment planning of rectal carcinoma.

Myerson R, Drzymala R. Myerson R, et al. Semin Radiat Oncol. 2003 Oct;13(4):433-40. doi: 10.1016/S1053-4296(03)00052-3. Semin Radiat Oncol. 2003. PMID: 14586832 Review.

Cite

Share

9

Cite

Share

Rationale for a phase I/II radiation dose-escalation study with concurrent amifostine (Ethyol) and infusional 5-FU chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma.

Myerson R. Myerson R. Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):86-90. doi: 10.1053/srao.2002.31380. Semin Radiat Oncol. 2002. PMID: 11917291

Cite

Share

10

Cite

Share

Early results from a phase I/II radiation dose-escalation study with concurrent amifostine and infusional 5-fluorouracil chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma.

Myerson R, Zobeiri I, Birnbaum E, Dietz D, Fleshman J, Kodner I, Picus J, Ratkin G. Myerson R, et al. Semin Oncol. 2002 Dec;29(6 Suppl 19):29-33. doi: 10.1053/sonc.2002.37360. Semin Oncol. 2002. PMID: 12577240 Clinical Trial.

Cite

Share